Skip to content
PP

Polar Pharma India

523333 BSE
Price unavailable
View as Markdown
MCP

No trades in 1Y

Key Insights

No strengths listed

Weaknesses

1
  • Company has low interest coverage ratio.

Growth Rate

Annual windows: The latest annual results are more than two years old, so no annual growth is shown.

Trailing twelve months: No quarterly results are reported.

Not shown: Quarterly Results. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.

Profit & Loss

₹ Cr
523333 profit and loss, annual, ₹ crore
Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Sales
46
19
26
0
0
11
16
Expenses
74
23
26
11
2
9
18
Operating Profit
−28
−5
0
−11
−2
2
−2
OPM %
−61%
−24%
−1.4%
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
19%
−13%
Other Income
46
−2
1
−42
0
0
0
Interest
3
5
5
4
12
13
15
Depreciation
3
3
2
2
2
2
2
PBT
12
−14
−7
−59
−16
−14
−19
Tax %
44%
−33%
−64%
15%
0%
0%
0%
Net Profit
6
−9
−3
−68
−16
−14
−19
EPS (₹)
5.28
−7.37
−2.09
−55.36
−13.12
−11.03
−15.4
Div. Payout %
0%
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
523333 balance sheet, annual, ₹ crore
Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Equity Capital
12
12
12
12
12
12
12
Reserves
−1
−9
−11
−79
−95
−109
−128
Borrowings
41
46
43
86
104
118
133
Other Liabilities
16
12
9
13
8
9
6
Total Liabilities
68
62
53
32
29
31
24
Fixed Assets
34
31
29
26
24
22
19
CWIP
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
Other Assets
34
30
25
6
5
9
4
Total Assets
68
62
53
32
29
31
24

Cash Flow

₹ Cr
523333 cash flow, annual, ₹ crore
Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Operating
20
−6
6
−40
2
−1
1
Investing
−1
1
1
0
0
0
0
Financing
−18
4
−6
39
−2
1
0
Net Cash Flow
2
−2
1
−1
0
0
1
Free Cash Flow
19
−6
6
−40
2
−1
1
CFO/OP
−73
142
−1,717
376
−120
−45
−34

Ratios

523333 financial ratios, annual
Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Debtor Days
100
190
90
—
—
59
4
Inventory Days
228
458
83
—
—
365
64
Days Payable
96
53
20
—
—
346
68
Cash Conversion Cycle
232
596
153
—
—
77
0
Working Capital Days
127
264
67
—
—
−35
−69
ROCE %
—
−11%
−4%
−35%
−21%
−1%
−20%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Polar Pharma insights

40 extracted metrics across FY06–FY26.

Shareholding Pattern

Not shown: Shareholding Pattern. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.

Documents

Frequently Asked Questions about Polar Pharma India

What does Polar Pharma India Ltd do?
Polar Pharma India Limited is an India-based company. The Company is engaged in dealing with latex prophylactics.
Where is Polar Pharma India Ltd (523333) listed?
Polar Pharma India Ltd trades under code 523333 on the BSE.

Company Information

Polar Pharma India Limited is an India-based company. The Company is engaged in dealing with latex prophylactics.

Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/523333.md for Polar Pharma India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More